ArticleProceedings of the National Academy of Sciences of the United States of America2016

Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells.

Shu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.